PASSAGE BIO INC
COM · CUSIP 702712100
46
institutional holders
29.4m
shares reported held*
$461.5mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $15.72.
Biggest buyers
| ORBIMED ADVISORS LLC | New | +7.0m |
| FRAZIER MANAGEMENT LLC | New | +5.0m |
| FMR LLC | New | +3.1m |
| New Leaf Venture Partners, L.L.C. | New | +2.5m |
| Vivo Capital, LLC | New | +2.2m |
| Boxer Capital, LLC | New | +1.9m |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New | +670.4k |
| BlackRock Inc. | New | +619.8k |
| Logos Global Management LP | New | +603.3k |
| ALKEON CAPITAL MANAGEMENT LLC | New | +505.0k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Lynx1 Capital Management LP
13D · may seek influence
+1.4 pts · filed 2026-07-02
Stated purposeThe Reporting Persons originally acquired the securities reported herein because they believe the securities are undervalued and represent an attractive investment opportunity and they continue to hold the shares of Common Stock reported herein for investment purposes. The Reporting Persons previously reported their beneficial ownership on Schedule 13G pursuant to Rule 13d-1(c) under the Act. As a result of the acquisition of additional shares of Common Stock described in Items 3 and 5(c), the Reporting Persons' aggregate beneficial ownership has equaled or exceeded 20% of the outstanding Common Stock. Accordingly, the Reporting Persons are no longer eligible to report on Schedule 13G under Rule 13d-1(c)(3) and are filing this Schedule 13D pursuant to Rule 13d-1(f)(1). On June 24, 2026, t… Full filing |
21.0% |
Holders, Q1 2020
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 1.86% of their portfolio | 7.0m $109.7m | New |
| FRAZIER MANAGEMENT LLC 8.95% of their portfolio | 5.0m $78.9m | New |
| FMR LLC 0.01% of their portfolio | 3.1m $49.4m | New |
| New Leaf Venture Partners, L.L.C. 11.77% of their portfolio | 2.5m $39.3m | New |
| Vivo Capital, LLC 3.18% of their portfolio | 2.2m $35.1m | New |
| Boxer Capital, LLC 2.04% of their portfolio | 1.9m $29.7m | New |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.34% of their portfolio | 670.4k $10.6m | New |
| BlackRock Inc. 0.00% of their portfolio | 619.8k $9.8m | New |
| Logos Global Management LP 3.44% of their portfolio | 603.3k $9.0m | New |
| ALKEON CAPITAL MANAGEMENT LLC 0.07% of their portfolio | 505.0k $8.0m | New |
| SPHERA FUNDS MANAGEMENT LTD. 1.18% of their portfolio | 478.2k $7.1m | New |
| VICTORY CAPITAL MANAGEMENT INC 0.01% of their portfolio | 418.6k $6.6m | New |
| Alyeska Investment Group, L.P. 0.13% of their portfolio | 408.2k $6.4m | Not comparable |
| HIGHLINE CAPITAL MANAGEMENT, L.P. 1.42% of their portfolio | 369.3k $5.8m | New |
| EMERALD ADVISERS, LLC 0.32% of their portfolio | 354.6k $5.6m | New |
| RA CAPITAL MANAGEMENT, L.P. 0.16% of their portfolio | 322.6k $5.1m | New |
| EMERALD MUTUAL FUND ADVISERS TRUST 0.32% of their portfolio | 321.0k $5.1m | New |
| MORGAN STANLEY 0.00% of their portfolio | 292.7k $4.6m | New |
| BAKER BROS. ADVISORS LP 0.03% of their portfolio | 275.0k $4.3m | New |
| HHLR ADVISORS, LTD. 0.05% of their portfolio | 250.6k $3.9m | New |
| Artal Group S.A. 0.19% of their portfolio | 250.0k $3.9m | New |
| Rock Springs Capital Management LP 0.15% of their portfolio | 225.0k $3.5m | New |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 194.3k $3.1m | New |
| Weiss Multi-Strategy Advisers LLC 0.11% of their portfolio | 179.8k $2.8m | New |
| MILLENNIUM MANAGEMENT LLC 0.01% of their portfolio | 163.9k $2.6m | New |
| Atom Investors LP 0.24% of their portfolio | 150.0k $2.4m | New |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 128.0k $2.0m | New |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 123.2k $1.9m | New |
| ArrowMark Colorado Holdings LLC 0.01% of their portfolio | 62.0k $977.0k | New |
| Marshall Wace North America L.P. 0.01% of their portfolio | 61.2k $965.0k | New |
| CAAS CAPITAL MANAGEMENT LP 0.28% of their portfolio | 50.0k $788.0k | First filing |
| FEDERATED HERMES, INC. 0.00% of their portfolio | 40.0k $630.0k | Not comparable |
| Cinctive Capital Management LP 0.08% of their portfolio | 21.5k $338.0k | New |
| NORGES BANK 0.00% of their portfolio | 20.0k $315.0k | Not comparable |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 14.5k $228.0k | New |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 12.7k $200.0k | New |
| Blackstone Inc. 0.00% of their portfolio | 12.0k $189.0k | New |
| VANGUARD GROUP INC 0.00% of their portfolio | 11.4k $181.0k | New |
| TD Asset Management Inc 0.00% of their portfolio | 10.5k $165.0k | New |
| Maven Securities LTD 0.10% of their portfolio | 10.4k $164.0k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 7.9k $125.0k | New |
| Pinz Capital Management, LP 0.18% of their portfolio | 4.2k $67.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 1.1k $18.0k | New |
| NewSquare Capital LLC 0.00% of their portfolio | 1.0k $16.0k | Not comparable |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 146 $2.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | New |